Skip to content

Evaluation of ultrafiltration control using blood volume monitor during hemodialysis

Evaluation of ultrafiltration control using blood volume monitor during hemodialysis - UF control using BVM during HD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000024670
Enrollment
60
Registered
2016-12-01
Start date
2016-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

maintenance hemodialysis

Interventions

Evaluation period: 8 weeks Methods: In each included HD patient, conventional HD and HD under the use of BV-UFC by BVM are performed, which are also crossed at 1st and 2nd HD day in each week, for 8

Sponsors

Division of Nephrology, First Department of Integrated Medicine, Jichi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients undergoing HD. HD duration is more than 3 months with stable condition. Patients with hemoconcentration after HD compared with before HD. Serum albumin concentration is more than 3.0 g/dL. HD session is 4 hour.

Exclusion criteria

Exclusion criteria: below age of 20 years. patients who are impossible to perform self-judgement. patients with body weight gain less than 1.0 kg. patients who take anti-hypertensive or anti-hypotensive medicine from one hour before HD to HD procedure. patients with frequent postural changes during HD. patients with a suspicion of vascular access resirculation. patients with old myocardial infarction. patients with angina pectoris. patients with severe cardiovascular diseases. patients with pregnancy or a possibility of pregnancy. patients who are thought inadequate by doctor.

Design outcomes

Primary

MeasureTime frame
Occurrence of intradialytic hypotensin

Secondary

MeasureTime frame
Management necessity to intradialytic hypotension Change of vlood volume after HD Change of blood pressure during HD Achievement of targeted fluid-management after HD

Countries

Japan

Contacts

Public ContactSusumu Ookawara

Saitama Medical Center, Jichi Medical University First department of Integrated Medicine

ookawaras@jichi.ac.jp048-647-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026